What is Evaluate?
Founded in 1996 and headquartered in Greater London, United Kingdom, Evaluate is a key player in the life sciences data sector. The company excels at collecting, calibrating, and connecting pharmaceutical data, providing critical commercial intelligence for the pharmaceutical and medical device industries. Its deep data capabilities position it as an essential resource for market analysis and strategic decision-making within the global healthcare landscape.
How much funding has Evaluate raised?
Evaluate has raised a total of $10.6M across 1 funding round:
Private Equity
$10.6M
Private Equity (2020): $10.6M with participation from HgCapital Trust
Key Investors in Evaluate
HgCapital Trust
HgCapital Trust is a private equity firm known for its investments in technology and business services companies, suggesting a focus on data-driven platforms and enterprise software solutions.
What's next for Evaluate?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth trajectory for Evaluate. This capital infusion is likely to fuel further expansion of its data collection and analytical capabilities, potentially enabling the company to broaden its market intelligence offerings and deepen its penetration into new therapeutic areas or geographical regions. The backing suggests confidence from investors in Evaluate's business model and its pivotal role in supporting innovation and commercial strategy within the pharmaceutical and medical device sectors.
See full Evaluate company page
